Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue. by Di Bisceglie, A. M. et al.
Br. J. Cancer (1986) 54, 779-785
Detection of alpha-foetoprotein messenger RNA in human
hepatocellular carcinoma and hepatoblastoma tissue
A.M. Di Biscegliel*, G.M. Dusheiko1, A.C. Paterson1, J. Alexander2,
D. Shouval3, C.-S. Lee4, R.P. Beasley4 & M.C. Kew'
'Dept. ofMedicine, University ofthe Witwatersrand Medical School, 2193 Johannesburg, South Africa;
2Medical University ofSouth Africa; 3Hadassah University Hospital, Jerusalem, Israel & 4University of
Washington Medical Research Unit and National Taiwan University, Taipei, Taiwan.
Summary Alpha-foetoprotein (AFP) synthesis, although repressed in normal adults, is increased in the
majority of patients with hepatocellular carcinoma (HCC). We have investigated whether active transcription
of the AFP gene may explain raised serum AFP concentrations in patients with HCC and hepatoblastoma by
assaying human tumour and non-neoplastic tissue by molecular hybridization for the presence of mRNA
encoding AFP. Ten operative HCC and six autopsy HCC specimens, two HCC cell lines, and one
hepatoblastoma specimen were examined. Total cellular RNA and poly-(A)+ RNA were extracted and AFP
mRNA sequences sought by dot-blot and Northern blot hybridisation to a human cDNA AFP probe.
Cellular AFP was localised by avidin-biotin staining. AFP mRNA was detected in 8/10 operative specimens,
as well as PLC/PRF/5 nude mouse tumours. Weaker hybridization was dectected in 4/6 autopsy specimens.
Signals of comparable intensity to that in operative tumours were detected in non-neoplastic tissue of 6
patients. AFP mRNA from nude mouse tumours migrated as a 20S discrete band on agarose gel
electrophoresis, whereas a more complex hybridization pattern was evident in human tumours. Positive
cytoplasmic immuno-staining for AFP was observed in 4 tumours and 2 corresponding non-neoplastic
specimens and in a HCC cell line. In non-neoplastic liver, AFP was localised in cells that appeared dysplastic.
Thus steady-state levels of AFP mRNA are detectable in human HCC tissue and surrounding non-neoplastic
liver. These findings may prove pertinent to an understanding of the genetic expression of AFP in malignant
hepatocytes, and the sequence of events leading to uncontrolled cellular proliferation.
Alpha-foetoprotein (AFP), a 72Kd alpha-I-globulin
with an uncertain biological function, is synthesized
during embryonic life by foetal yolk sac, liver and
intestinal tract. Its synthesis is repressed in children
and adults so less than 20ngml-1 (by radio-
immunoassay) is found in serum of healthy adults
(Wepsic & Kirkpatrick 1979; Kew 1974; Crandall,
1981).
Serum AFP concentrations are increased in the
majority of patients with hepatocellular carcinoma
(HCC), hepatoblastoma and germ cell tumours
(Abelev, 1971; Purves et al., 1970; Kew, 1983; Bellet
et al., 1984). Histochemical studies have shown the
presence of AFP in malignant hepatocytes
(Hirohashi et al., 1983), and serum AFP concen-
trations rapidly return to normal after complete
resection of HCC (Chen et al., 1982; Johnson &
Williams, 1982), indicating that malignant hepato-
cytes are responsible for production of AFP.
Possible explanations for the reinitiation of AFP
synthesis by neoplastic hepatocytes include either
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increased transcription of the AFP gene or post-
translational modifications affecting AFP
production. DNA complementary to human AFP
messenger RNA (mRNA) has recently been
synthesized, and the availability of specific cDNA
hybridization probes will greatly facilitate the
analysis of AFP gene expression in human diseases
(Morinaga et al., 1982). We have investigated
whether active transcription of the AFP gene may
account for raised serum AFP concentrations in
patients with HCC and hepatoblastoma by assaying
human tumour tissue by molecular hybridization
for the presence ofmRNA encoding for AFP.
Materials and methods
Human HCC and hepatoblastoma
Operative HCC specimens were obtained from
seven Taiwanese and two Black South African
hepatitis B surface antigen (HBsAg) positive
carriers whose small tumours were diagnosed by
ultrasonography and serum AFP measurement.
Autopsy specimens obtained from six Black South
African patients with HCC were also studied.
Serum AFP concentrations were normal in two,
<400ngml 1 in three and between 400 and
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312,617 ngml-1 in the remaining patients. In all,
twelve patients with HCC were HBsAg-positive
(Table I). Resected hepatoblastoma tissue from a 2-
year old boy was also analysed; his serum was
HBsAg-negative with an AFP concentration of
1000ngml-1. Both neoplastic and non-neoplastic
liver were thus available in ten patients (Table I).
Resected tissue was immediately frozen in liquid
nitrogen and stored at -70°C until used.
Autospy specimens were collected within one
hour of death, and stored at -70°C: several had
however thawed at least once. Portions of each
specimen were formalin-fixed for immunocyto-
chemical study and histological examination.
Human HCC cell lines
A cell line, PLC/PRF/5, derived by Alexander et al.
(1976) from a male HBsAg carrier with HCC
whose serum had raised AFP values was examined.
Although this cell line does not secrete AFP in
culture, when transplanted into athymic (nude)
mice it grows into a solid tumour and produces
AFP detectable in the mouse serum (Bassendine et
al., 1980). Three such nude mouse PLC/PRF/5
tumours were collected. Serum AFP levels in the
mice were unknown in one animal and 2,000 and
7,600ngml -1 respectively, in the other two.
HepG2, an AFP-producing human hepatoblastoma
line was also studied (Knowles et al., 1980).
Controls
Hepatic tissue obtained at the time of renal trans-
plantation from two previously healthy donors was
used as a negative control. Because foetal liver has
high levels of AFP transcription, liver from an eight
week human abortus was used as a positive control.
Isolation ofmRNA
Total cellular RNA was isolated by the guan-
idinium isothiocyanate extraction method of
Chirgwin et al. (1979). Approximately 0.5-1 g of
each tumour and corresponding non-tumorous liver
was homogenized in 4ml of 4M guanidinium iso-
thiocyanate, sarkosyl, sodium citrate pH 7.0 with
mercaptoethanol. The homogenate was clarified by
centrifuging at 7650g for 10min at 10°C; the
supernatant was centrifuged through a 1.2ml
cushion of CsCl at 35,000rpm for 12h at 20°C in
Beckman SW 60: 1 rotor to pellet total cellular
RNA. After ethanol precipitation, RNA was stored
in 70% ethanol in liquid nitrogen. Poly-adenylated
RNA [poly-(A)+ RNA; mRNA] was separated by
repeated oligo-(dT)cellulose affinity chromato-
graphy (Bethesda Research Laboratories, Md)
(Aviv & Leder, 1972). Poly-(A)+ RNA was eluted
from the oligo-(dT)cellulose in buffer of low ionic
strength (10mm Tris-HCl, 1 mm EDTA), pooled,
precipitated in ethanol and stored in liquid
nitrogen.
Dot-blot analysis
AFP mRNA sequences were sought by dot-blot
hybridization using the method of Thomas (1980).
In an attempt to obtain an estimate of the amount
of AFP mRNA present in each sample, a known
quantity of RNA based on OD260 reading was
spotted on to each filter and compared to AFP
cDNA in serial dilutions on the same filter. Hybrid-
ization signals were evaluated semi-quantitatively
(Figure 1). Up to 5-10,Ig of poly-(A)+ RNA were
serially diluted and spotted directly onto a dry
nitrocellulose sheet which had been pretreated with
water, 20 x SSC and dried. The filter was then
baked at 80°C in a vacuum oven, treated with
20mM Tris-HCl (pH 8.0) for 5-10min at 100°C,
and prehybridized and hybridized as described
below.
Northern blot analysis
mRNA and total cellular RNA were separately
analysed by Northern blotting. Total cellular RNA
(25,ug) or poly-(A)+ RNA (2-5ig) were dissolved
in 50% formamide, 6% formaldehyde and MOPS
buffer (20mm morpholinopropanesulfonic acid,
5mm sodium acetate, 1 mm EDTA), then incubated
at 60°C for 15min and electrophoresed in 1%
agarose gels in MOPS buffer. Samples were
transferred to nitrocellulose paper, washed gently in
water and baked.
Hybridization and autoradiography
Samples were hybridized to a 0.84kb cDNA human
AFP probe cloned from testicular embryonal
carcinoma grown in nude mice (pHAF2) (Morinaga
et al., 1982). The probe was purified from pBR322
plasmid by Pst I digestion (Bethesda Research
Laboratories, Md.) and preparative gel electro-
phoresis, and labelled by nick translation with (32)p
dCTP (Amersham, UK) to a specific activity of 2-
5 x 10 -7dpmug-I (Rigby et al., 1977). Prehybri-
dization was performed at 42°C according to the
method of Wahl et al. (1979). for 12h.
Hybridization was performed under conditions of
high stringency in a solution containing 50%
formamide and 10% sodium dextran sulphate at
37°C. Filters were subsequently washed 3-5 times
in 2 x SSC, 0.1% SDS at 37°C for 30min each. In
selected instances, filters were washed in 0.1 x SCC,
0.1% SDS at 50°C. Filters were then dried and
exposed to Kodak XAR5 autoradiographic films
with Dupont lightning Plus screens at -70°C for
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Serum AFP
Serum AFP concentrations were measured by
radioimmunoassay (Amersham, UK).
Immunohistochemistry
All tissues were fixed in 10% formalin in saline and
5,um sections were cut from paraffin blocks.
Immunostaining for AFP was performed by
incubating tissue sections with rabbit anti-AFP,
biotinylated secondary antibody and preformed
avidin-biotin-peroxidase complexes (Vectorstain,
Vector laboratories, Ca.). AFP was localized by
addition of peroxidase substrate (Hsu et al., 1981).
Sections were stained with haematoxylin and eosin
for routine histological examination. Dysplastic
cells with hyperchromatic, pleomorphic nuclei,
multinucleate cells and the presence of prominent




Each gram of tissue yielded approximately 1 mg of
total cellular RNA, although the yield from
autopsy tissue was often considerably less than this.
From 1004g of total RNA about 3 to 5 ug of poly-
(A)+ RNA was recovered by oligo-(dT)-cellulose
affinity chromatography.
Dot-blot hybridization
Dot-blots were scored as negative or from 1 + to
3+ positive based on intensity of hybridization on
autoradiogram. AFP mRNA was detected in
tumour tissue of 8 of 10 operative specimens (Table
I). Much weaker hybridization signals were detected
in 4 of 6 autopsy specimens, and thus these tissues
were not studied further. Low levels of AFP
mRNA were also noted in hepatoblastoma tissue.
Signals of comparable intensity to neoplastic tissue
were obtained from surrounding non-neoplastic
liver in certain patients (Figure 1). Serum AFP
levels in the 2 resected tumours negative for AFP
mRNA, were <20 and 3,667ngml-1, respectively
(Table I).
The intensity of hybridization signals did not
seem to be related to serum AFP concentration as
some of the strongest signals were found -in those
patients with relativelv low AFP levels. In one
patient AFP mRNA was detected in non-neoplastic
liver but not in the tumour. Hybridization signals
were not found in either of the 2 negative controls,
but were present in foetal liver. The strongest
hybridization signals were found in PLC/PRF/5
nude mouse tumours, although no AFP mRNA




Figure I Dot-blot hybridization to mRNA from human HCC and solid PLC/PRF/5 tumour cell line to AFP
cDNA probe. In an attempt to determine relative quantities of AFP mRNA, hybridization signals were
graded in intensity from 0 to 3+: trace, weak hybridization seen only on 7 day autoradiogram; 1+, visible at
1 to 1/2 dilution at 3 days; 2+, up to 1/16 dilution at 3 days; 3+, up to 1/64 dilution at 3 days. (a) mRNA
from solid PLC/PRF/5 tumour grown in nude mouse, 1 ig in doubling dilutions. (b) and (c) mRNA from
tumour (b) and non-tumorous liver (c) of patient #8, using 5 tg spotted in doubling dilutions. 3 day
autoradiogram.782 A.M. DI BISCEGLIE et al.
Table I Clinical details of patients with results of staining for AFP and testing for AFP mRNA in tissues studied.
Serum/Supernatant Tumour Non-tumourous liver
AFP mRNA AFP mRNA
Tissue AFP HBsAg Dot Blot Northern AFP PAP Dot Blot AFP PAP Dysplasia
Operative 1 20 - - - - - - -
HCC 2 1005 + + - - + + +
3 174 + + - - + - +
4 10800 + ++ + ++ ND - +
5 248 + + - + - - +
6 21436 + + - - + - +
7 3667 + - - + + + + +
8 3559 + +- + + - +
9 5200 + ++ + - - - -
10 1000 - + - tr tr
PLC/PRF/5 1 2000 ND + - +
(solid tumour) 2 7600 ND + + +
3 ND ND + + +
Hep G2 + + +
PLC/PRF/5 - + - +
Autopsy 1 62235 - tr
HCC 2 14073 - tr
3 10000 + -
4 312617 tr
5 20000 + tr
6 250 + tr
Normal 1 -
2 - -
Foetal 1 ND ND + + + + +
liver
In all cases, 5jg of mRNA was dotted in serial dilution, except for autopsy HCC where 10 g was used. Operative HCC:
#1-7, Taiwanese patients; #8-9, Black South African patients; #10, hepatoblastoma. PLC/PRF/5: (solid tumour) # 1-3,
grown to solid tumour in nude mice. HepG2 and PLC/PRF/5: in tissue culture. Autopsy HCC: As only weak hybridization
signals to AFP cDNA were obtained from these samples, they were not studied completely. Normal: Normal liver tissue from
renal donors at the time of death, as a negative control. Foetal liver: From an 8-week human abortus, as a positive control.
ND: not done. PAP: peroxidase-antiperoxidase staining, graded as 0 to 3+. 1+, <10% cells positive. 2+, 10-50% cells
positive. 3+, >50 cells positive.
Northern blot
Northern blot analysis of RNA from HCC and
corresponding non-neoplastic liver showed the
presence of AFP transcripts in 6 tissues, 2 of which
were PLC/PRF/5 nude mouse tumours, Hep G2 in
culture and 3 human HCC. Where AFP mRNA
migrated as a discrete band, it was in the region of
20S RNA species (Figure 2). This is in keeping with
the size of human AFP transcripts deduced from
AFP cDNAs of a human testicular cell line
(Morinaga et al., 1983), but has not been shown
previously in human HCC. In the other 3 human
tumours positive by Northern blot (Figure 2) it is
apparent that a more complex hybridization pattern
is present; indeed, patient 4 shows a smear of
hybridization over a wide range of AFP sizes, while
patient 6 appears to show 2 distinct transcripts.
Although all operative tumours were analysed by
Northern blot, only 3 demonstrated the presence of
AFP mRNA; we feel that that this discrepancy
between dot-blot and Northern blot is accounted
for by degradation of RNA, which might allow a
signal to be seen from a concentrated RNA dot,
and not from RNA widely separated on a gel. In
addition, we believe that degradation of RNA
occurred in storage after dot-blots and before
Northern blots were done.
Immunohistochemtisty
Positive cytoplasmic staining was observed in 4
tumours and 3 corresponding non-neoplastic livers,
as well as within foetal liver and 3 PLC/PRF/5 cell
line tumours. Weakly positive staining was present
in the hepatoblastoma. In non-neoplastic liver, AFPALPHA-FOETOPROTEIN mRNA IN HUMAN HEPATOCELLULAR CARCINOMA
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Figure 2 Results of Northern blots of tu
using AFP CDNA probe for hybridization
a,b,c,e,f) of mRNA electrophoresed on
gel in the presence of formaldehyde and M
transferred to nitrocullulose for hybridizati
PLC/PRF/5 tumour #3: (b) solid PLC/PF
#2; (c) HepG2 cells in culture; (d) 25
cellular RNA from operative tumour #4;
tumour #9; (f) operative tumour #6; plas
as positive control, 0.025Mg digested with
position of 16S and 23S ribosomal RNA a
size markers.
was generally localized in cells tha
dysplastic. AFP staining was not seen
which AFP mRNA was not found.
Discussion
We have estimated AFP gene transcript
tissue by using a cDNA probe to
mRNA in neoplastic tissue. This stud)
to report measurable AFP mRNA in E
tissue although AFP and albumin nr
recently been detected in a human he
line by in situ hybridization (Bret
Tamaoki 1985). Quantities of AFP n
detected by dot-blot hybridization unde
of high stringency in 11 of 15 operative and
autopsy tumours, two HCC cell lines and one
hepatoblastoma. As expected, fewer autopsy than
operative specimens had mRNA detectable by dot-
blot assay almost certainly as a result of RNA
degradation, and indeed RNA degradation proved
the limiting factor in these studies. Our results
suggest that steady-state quantities of AFP mRNA
are present in malignant hepatocytes, and that
active transcription of the AFP gene is occurring.
- 23S We cannot comment however, on the rate of AFP
gene transcription in neoplastic cells, nor on the
relative roles of gene transcription versus mRNA
translation in attempting to explain the observed
- 16S increase in serum AFP levels in HCC.
The majority of patients with HCC have elevated
serum AFP levels; transient elevations may also
occur in acute and chronic hepatitis with active
hepatic regeneration, and after partial hepatectomy
in animals although not necessarily in humans
(Furukuwa et al., 1984). The molecular mechanism
of increased AFP production in the latter
pathological states remains uncertain. In rats after
partial hepatectomy, chemical injury, exposure to
chemical carcinogens, or with HCC, AFP
production is roughly proportional to the amount
of translatable mRNA present (Belanger et al.,
1983). The major control of AFP production is
imour RNA therefore probably at the level of gene transcription
. 5pg (lanes (Sell et al., 1980; Tilghman & Belayew 1982). The
% agarose cellular mechanism of induction of AFP synthesis
iOPS buffer, in malignant hepatocytes is also obscure and it is
ion. (a) solid
UF/5 tumour uncertain at which stage of differentiation or
~ig of total tumour size serum AFP values begin to rise.
(e) operative Although immunohistochemical staining has shown
,mid pHAF2 AFP to be present in malignant hepatocytes
i Pst I. The (Dempo et al., 1983), these techniques are relatively
ire shown as insensitive and do not necessarily reflect AFP
induction in hepatocytes. In contrast, estimation of
AFP mRNA provides an assessment of AFP
production at the gene level. For example,
it appeared expression of AFP and albumin in the perinatal
in tissues in period are regulated by reciprocal transcription of
AFP and albumin mRNA. The relative quantities
of AFP and albumin mRNAs in murine liver
correlate closely with the decline in AFP synthesis
and concomitant increase in albumin synthesis just
prior to birth (Tilghman & Belayew 1982).
Lion in HCC Increased levels of AFP mRNA have also been
detect AFP found in regenerating mouse liver (Goyette et al.,
y is the first 1983) in parallel with a cellular oncogene suggesting
iuman HCC that AFP production may be turned on by some
nRNA have aspect of cell growth. AFP expression in transplant-
patoma cell able rat HCC is controlled by modulation of the
borowicz & steady state concentration of AFP mRNA, and not
nRNA were by AFP gene amplification or rearrangement in
-r conditions neoplastic liver. There is as yet no evidence for
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post-transcriptional control of AFP gene expression
(Nahon et al., 1982).
We have shown AFP in non-tumorous liver
tissue by immunoperoxidase staining, and this was
most apparent in dysplastic cells noted histo-
logically. It is of particular interest that comparable
levels of AFP mRNA were found in both neo-
plastic and non-neoplastic liver in a few patients.
This finding suggests that steady-state AFP trans-
cription may begin prior to the development of
histologically obvious or symptomatic HCC, i.e.
such dysplastic cells have been altered in some way
along the path to malignancy. AFP has previously
been demonstrated histochemically in dysplastic
cells adjacent to HCC, indicating that these cells
have some of the properties of embryonal or
malignant hepatocytes (Okita et al., 1977). Other
investigators have however not confirmed this
finding, even in the presence of cirrhosis (Anthony,
1976). AFP can frequently be visualised in atypical
'oval cells' after carcinogen exposure in rats
exposed to carcinogens, although the relationship of
such cells to those that ultimately become
malignant is not known (Koen et al., 1983).
Although we cannont exclude the encroachment of
malignant cells into adjacent liver, we have
interpreted the finding of AFP mRNA in non-
tumorous liver to mean that increased AFP
production may occur in non-neoplastic hepato-
cytes in some patients.
It is also interesting that AFP transcription is
turned on in solid PLC/PRF/5 tumours compared
to the same cells in vitro. Possibly some type of
unknown cell-cell interaction not present in mono-
layer cultures induces AFP transcription when the
cells grow into a three-dimensional tumour, just as
occurred in the original patient from whom this line
was derived.
These preliminary experiments suggest that
further dynamic studies of constitutive and induced
levels of AFP mRNA in human cirrhotic and HCC
tissue may prove useful in explaining AFP
expression in neoplasia. In endemic areas of HBsAg
infection, mass screening programs to detect small
HCC have begun. As a result, the incidence of
resectable tumours has increased. The availability
of operative human HCC and non-neoplastic tissue
will provide the opportunity to minimize mRNA
degradation in tissue specimens and thus allow in-
depth studies of AFP mRNA. An understanding of
the genetic expression of AFP in malignant hepato-
cytes may assist in tracing the cumulative sequence
of events whereby hepatocytes develop a malignant
phenotype with uncontrolled cellular proliferation.
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